BPCP Income Statement - TTM - BioPharma Credit PLC

Income Statement (TTM)

BioPharma Credit PLC Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31
Revenue	111	110	112	114	109	104	116	128	173	218	219	221	178	136	136	136	143	150
Change (%)		-1.08	1.65	1.63	-4.30	-4.50	11.53	10.34	35.33	26.11	0.59	0.59	-19.25	-23.85	0.23	0.23	5.01	4.77
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales
Change (%)
% of Revenue

Gross Operating Profit	111	110	112	114	109	104	116	128	173	218	219	221	178	136	136	136	143	150
Change (%)		-1.08	1.65	1.63	-4.30	-4.50	11.53	10.34	35.33	26.11	0.59	0.59	-19.25	-23.85	0.23	0.23	5.01	4.77
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

SG&A	25	21	21	21	20	19	19	19	27	36	36	36	31	27	27	27	27	28
Change (%)		-17.34	-0.49	-0.49	-4.16	-4.34	-0.09	-0.09	44.62	30.85	-0.17	-0.17	-11.76	-13.33	-0.67	-0.68	1.50	1.48
% of Revenue	22.70	18.97	18.57	18.18	18.21	18.24	16.34	14.80	15.81	16.41	16.28	16.16	17.66	20.10	19.92	19.73	19.08	18.48

R&D
Change (%)
% of Revenue

OpEx	25	21	21	21	20	19	19	19	27	36	36	36	31	27	27	27	27	28
Change (%)		-17.34	-0.49	-0.49	-4.27	-4.46	0.01	0.01	44.76	30.92	-0.22	-0.22	-11.76	-13.33	-0.52	-0.52	1.58	1.55
% of Revenue	22.70	18.97	18.57	18.18	18.19	18.20	16.32	14.79	15.82	16.42	16.29	16.16	17.66	20.10	19.95	19.80	19.15	18.56

Operating Income	86	89	91	93	89	85	97	109	146	182	184	185	147	108	109	109	116	122
Change (%)		3.69	2.16	2.11	-4.31	-4.50	14.09	12.35	33.70	25.20	0.75	0.74	-20.70	-26.10	0.42	0.42	5.86	5.53
% of Revenue	77.30	81.03	81.43	81.82	81.81	81.80	83.68	85.21	84.18	83.58	83.71	83.84	82.34	79.90	80.05	80.20	80.85	81.44

Interest Expense
Change (%)
% of Revenue

Net Income	86	89	91	93	89	85	97	109	146	182	184	185	147	108	109	109	116	122
Change (%)		3.71	2.18	2.13	-4.33	-4.53	14.08	12.34	33.72	25.22	0.76	0.75	-20.70	-26.10	0.42	0.42	5.86	5.54
% of Revenue	77.27	81.02	81.44	81.84	81.81	81.79	83.65	85.17	84.16	83.56	83.70	83.84	82.34	79.90	80.05	80.20	80.85	81.44

Source: Capital IQ

DE:B3P	€0.78
GB:BPCR	US$0.91
US:BOPCF
GB:BPCRL

BioPharma Credit PLC - Income Statement (TTM)

Income Statement (TTM)

Other Listings